Trials for new Alzheimer’s drugs have been failing a lot, lately. But it may be premature to abandon these drugs altogether.
Articles on Beta-amyloid
Displaying 21 - 25 of 25 articles
A lot of Alzheimer’s treatments focus on removing plaques in the brain. But could this be the wrong target?
The first clinical trial examining a drug to treat Alzheimer’s was begun 30 years ago. There is still no cure and no known way to prevent the disease. Two factors may contribute to that.
Researchers have found evidence of the same brain pathologies in dolphins that are present in the brains of humans who died with Alzheimer’s. What might this suggest about Alzheimer’s in humans?
An important cell function called endocytosis is revealing a lot about how Alzheimer’s develops.
Top contributors
-
Research Fellow in Neuroimmunology, UCL
-
Professeur, Université Laval
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
PhD student, Université Laval
-
Ph.D. Candidate in Neuroscience, University of Virginia
-
Professor and Chair in Ageing and Alzheimer’s Disease, Edith Cowan University
-
Senior Lecturer in Cell Biology, University of Lancashire
-
Postdoctoral Researcher in Neuroscience, University of Sussex
-
Assistant Scientist, University of Florida
-
Professionnel de recherche, Université Laval
-
Postdoctoral Researcher, Karolinska Institutet
-
PhD Candidate, University of Sussex
-
Professor of Neurology and Neuroscience, University of Florida
-
NIHR Doctoral Fellow in Public Health, University of Cambridge